Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001740837-25-000003
Filing Date
2025-01-14
Accepted
2025-01-14 13:49:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4861
  Complete submission text file 0001740837-25-000003.txt   6811
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Subject) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-37393 | Film No.: 25528785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11747 NE 1ST STREET SUITE 205 BELLEVUE WA 98005
Business Address 11747 NE 1ST STREET SUITE 205 BELLEVUE WA 98005 4254558896
AltraVue Capital, LLC (Filed by) CIK: 0001740837 (see all company filings)

EIN.: 811081432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A